Monkeypox Includes Mucocutaneous Involvement in Almost All Cases Monkeypox Includes Mucocutaneous Involvement in Almost All Cases
Systemic features usually but not always precede cutaneous involvement, which is seen in more than 90% of patients, according to Alba Catal à, MD.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - October 4, 2022 Category: Dermatology Tags: Infectious Diseases News Source Type: news

Image-Guided Superficial Radiation as First-line in Skin Cancer? Image-Guided Superficial Radiation as First-line in Skin Cancer?
For non-melanoma skin cancer, image-guided superficial radiation therapy offered comparable disease control to Mohs surgery. The study was published as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 30, 2022 Category: Dermatology Tags: Hematology-Oncology News Source Type: news

Hormones' Impact Described in Transgender Rheumatology Patients Hormones' Impact Described in Transgender Rheumatology Patients
Gender-affirming hormone therapy does not need to be a strict contraindication in transgender patients with rheumatic disease, an author of a new case series and systematic review said.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 30, 2022 Category: Dermatology Tags: Rheumatology News Source Type: news

Alopecia Areata: Positive Data Reported for Two JAK Inhibitors Alopecia Areata: Positive Data Reported for Two JAK Inhibitors
JAK inhibitor therapy is hailed as"transformative" for patients with alopecia areata by one of the investigators reporting study results.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 29, 2022 Category: Dermatology Tags: Dermatology News Source Type: news

USPSTF: Screen At-Risk, Nonpregnant People for Syphilis USPSTF: Screen At-Risk, Nonpregnant People for Syphilis
Providers should continue screening sexually active, nonpregnant adolescents and adults for syphilis, according to a United States Preventive Services Task Force report.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 28, 2022 Category: Dermatology Tags: Infectious Diseases News Source Type: news

Losing and Preserving Dignity Losing and Preserving Dignity
"We push to reduce backlogs, offer same-time virtual care, work to reduce costs. We ' ve driven medicine to the efficient and left little of the dignity it seems," observes Jeffrey Benabio, MD, MBA.MDedge (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 28, 2022 Category: Dermatology Tags: Dermatology Commentary Source Type: news

' Amazing' Data for Cheap Beta-Blocker Gel for Diabetic Foot Ulcers'Amazing' Data for Cheap Beta-Blocker Gel for Diabetic Foot Ulcers
Esmolol, a widely available and cheap beta-blocker, shows statistically significant superiority over the standard of care for diabetic foot ulcers, according to new, ' potentially game-changing ' phase 3 data.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 21, 2022 Category: Dermatology Tags: Diabetes & Endocrinology News Source Type: news

Brodalumab Suicide Risk Similar to Other Biologics, Study Finds Brodalumab Suicide Risk Similar to Other Biologics, Study Finds
Researchers evaluated data on the number of completed suicides for brodalumab and 10 other biologics approved for psoriasis from the FDA ' s Adverse Events Reporting System through the end of 2021.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 19, 2022 Category: Dermatology Tags: Dermatology News Source Type: news

Apremilast Alleviates Severe Psoriasis in Some Children, Data Show Apremilast Alleviates Severe Psoriasis in Some Children, Data Show
Proportionally more children treated with apremilast than with placebo achieved a Physician ' s Global Assessment response at week 16, with no new safety concerns highlighted.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 19, 2022 Category: Dermatology Tags: Dermatology News Source Type: news

Hope Shines Bright for Hidradenitis Suppurativa Treatments Hope Shines Bright for Hidradenitis Suppurativa Treatments
Secukinumab and the investigational drug brepocitinib were shown to alleviate the effects of the chronic and painful skin condition in separate, unrelated trials.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 16, 2022 Category: Dermatology Tags: Dermatology News Source Type: news

Litifilimab Meets Primary Endpoint in Phase 2 Lupus Trial Litifilimab Meets Primary Endpoint in Phase 2 Lupus Trial
Treatment group saw greater reduction in number of tender and swollen joints.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 13, 2022 Category: Dermatology Tags: Rheumatology News Source Type: news

Novel Study Offers Clues to Sex Bias in Lupus Incidence Novel Study Offers Clues to Sex Bias in Lupus Incidence
Researchers compared immune cells in cisgender and transgender subjects to investigate the role of sex hormones independently from chromosomes in a study on sex bias in autoimmune disease.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 12, 2022 Category: Dermatology Tags: Rheumatology News Source Type: news

FDA Approves Oral TYK2 Inhibitor for Treating Psoriasis FDA Approves Oral TYK2 Inhibitor for Treating Psoriasis
Deucravacitinib, an oral, selective tyrosine kinase 2 (TYK2) inhibitor, is the first drug in this class to be approved.FDA Approvals (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 12, 2022 Category: Dermatology Tags: Dermatology News Alert Source Type: news

Roflumilast Foam Effectively Eases Seborrheic Dermatitis Roflumilast Foam Effectively Eases Seborrheic Dermatitis
Results of the pivotal phase 3 STRATUM trial have been revealed for the first time and show a clear benefit for the novel topical therapy in managing the common skin condition.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 10, 2022 Category: Dermatology Tags: Dermatology News Source Type: news

Polypodium Leucotomos Found to Reverse AK Skin Damage Polypodium Leucotomos Found to Reverse AK Skin Damage
Investigators compared the impact of topical PLE with or without oral PLE with topical photoprotection alone on several AK measures and skin changes evaluated with reflectance confocal microscopy.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 10, 2022 Category: Dermatology Tags: Dermatology News Source Type: news